SCHEMBL9526291

SCHEMBL9526291

CC(C)COC(=O)C(CCc1ccccc1)NC1CSC(c2cccc3ccccc23)CN(CC(=O)O)C1=O

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACE P12821 9/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9527641 0.93 ACE (0.51) ACE
SCHEMBL9530659 0.91 ACE (0.48) ACE
SCHEMBL9526284 0.90 ACE (0.45) ACE
SCHEMBL9526900 0.89 ACE (0.59) ACE
SCHEMBL9525832 0.88 ACE (0.44) ACE
SCHEMBL9529844 0.88 ACE (0.43) ACE
SCHEMBL9526563 0.87 ACE (0.41) ACE
SCHEMBL9526453 0.86 ACE (0.46) ACE
SCHEMBL9526887 0.85 ACE (0.46) ACE
SCHEMBL9527070 0.84 ACE (0.48) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0365045-B1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1993-12-01 EP disclosed
US-4699905-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1987-10-13 US disclosed